查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
內視鏡黏膜下剝離術市場 - 全球及區域分析：依適應症、產品、最終使用者、地區及國家的分析及預測（2025-2035年）
市場調查報告書
商品編碼
1808109

內視鏡黏膜下剝離術市場 - 全球及區域分析：依適應症、產品、最終使用者、地區及國家的分析及預測（2025-2035年）

Endoscopic Submucosal Dissection Market - A Global and Regional Analysis: Focus on Indication, Product, End user, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 110 Pages | 商品交期: 1-5個工作天內

價格

內視鏡黏膜下剝離術是一種微創手術，用於切除消化道（特別是食道、胃和大腸）內的腫瘤和病變。

與傳統手術不同，內視鏡黏膜下剝離術（EDS）可使用內視鏡將腫瘤及其深層組織完全切除。手術過程中，一根裝有攝影機的細而靈活的管子（內視鏡）被插入患者的消化道，以觀察異常生長或病變。

手術過程中，醫師使用特殊器材解剖黏膜下層（黏膜下層組織，即消化道內壁的最內層），切除目標病變，同時盡量保留周圍正常組織。內視鏡黏膜下層剝離術對治療早期癌症以及不適合其他內視鏡技術（例如息肉切除術）的大型表皮腫瘤尤其有效。

此手術的主要優點之一是能夠精準切除腫瘤，無需進行更具侵入性的手術，縮短恢復時間、減輕疼痛並最大程度減少疤痕。此外，此手術還能保留消化道功能，使其成為許多患有某些類型癌症和良性病變患者的首選治療方案。然而，該手術需要高超的技能和專業知識，通常在專科醫療中心進行。

胃腸道癌症（包括食道癌、胃癌和大腸癌）的發生率上升是市場的主要成長要素之一。這些癌症通常在早期就能發現，並可透過內視鏡黏膜下剝離術進行治療。這種微創手術可以整塊切除腫瘤，降低復發風險並減少對更具侵入性的手術的需求。

不健康飲食、久坐不動的生活方式以及人口老化等因素導致胃腸道癌症發生率上升，導致胃腸道疾病病例大幅增加。這些疾病通常在晚期診斷出來，因此早期發現和早期療育變得越來越重要。

此外，內視鏡技術的進步，例如複雜的成像系統和改進的電外科器械，提高手術的安全性和有效性，推動市場需求。此外，人們對能夠保留器官功能並促進更快恢復的微創治療的日益偏好也促進了市場的成長。

因此，胃腸道癌症的增加、內視鏡技術的進步以及向微創治療的轉變是推動內視鏡黏膜下剝離術市場成長的主要因素。

本報告調查了全球內視鏡黏膜下剝離術市場，並總結了主要趨勢、市場影響因素分析、法律制度、技術和專利分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

第1章 全球內視鏡黏膜下剝離術市場：產業展望

  • 市場趨勢
  • 法律規範
  • 專利分析
  • 案例研究
  • 產品基準
  • 市場動態
    • 影響分析
    • 市場促進因素
    • 市場挑戰
    • 市場機會

第2章 全球內視鏡黏膜下剝離術市場（依產品）

  • 胃鏡檢查和大腸鏡檢查
  • 刀
  • 注射劑
  • 組織牽開器
  • 抓鉗/夾
  • 其他

第3章 全球內視鏡黏膜下剝離術市場（依適應症）

  • 胃癌
  • 大腸直腸癌
  • 食道癌

第4章 全球內視鏡黏膜下剝離術市場（依最終用戶）

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第5章 全球內視鏡黏膜下剝離術市場（依地區）

  • 北美洲
    • 主要調查結果
    • 市場動態
    • 市場規模及預測
  • 歐洲
    • 主要調查結果
    • 市場動態
    • 市場規模及預測
  • 亞太地區
    • 主要調查結果
    • 市場動態
    • 市場規模及預測
  • 世界其他地區
    • 主要調查結果
    • 市場動態
    • 市場規模及預測

第6章 全球內視鏡黏膜下剝離術市場：競爭格局與公司概況

  • 關鍵策略和發展
  • 公司簡介
    • Fujifilm Holdings Corporation
    • Olympus Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • Sumitomo Bakelite Co., Ltd.
    • Hoya Corporation
    • Creo Medical Group PLC
    • Conmed Corporation
    • Steris PLC
    • MTW Endoskopie Manufaktur
    • Karl Storz SE & Co. KG
    • Cook Medical
    • Leo Medical Co., Ltd.
    • Hangzhou AGS Medical Technological Co., Ltd.
    • Beijing ZKSK Technology Co., Ltd.

第7章 調查方法

Product Code: BHL3238SA

Global Endoscopic submucosal dissection Market, Analysis and Forecast: 2025-2035

Endoscopic submucosal dissection is a minimally invasive surgical technique used to remove tumors or lesions from the gastrointestinal (GI) tract, particularly in the esophagus, stomach, and colon. Unlike traditional surgical methods, endoscopic submucosal dissection allows for the complete resection of tumors, including deeper layers of tissue, using an endoscope. The procedure involves the insertion of a thin, flexible tube with a camera (endoscope) into the patient's digestive tract, where it enables surgeons to locate and visualize abnormal growths or lesions.

During the procedure, the surgeon uses specialized tools to dissect the submucosal layer (the layer of tissue beneath the mucosa, or the innermost lining of the GI tract) and remove the targeted lesion, while preserving the surrounding healthy tissue. endoscopic submucosal dissection is particularly effective for treating early-stage cancers and large, superficial tumors that may not be suitable for other endoscopic methods, such as polypectomy.

One of the primary advantages of endoscopic submucosal dissection is that it allows for precise removal of tumors without the need for more invasive surgeries, thus offering faster recovery times, less pain, and minimal scarring. Additionally, it helps in preserving the function of the GI tract, making it a preferred option for many patients with certain types of cancer or benign lesions. However, the procedure requires high skill and expertise and is typically performed in specialized medical centers.

One of the key drivers of the Endoscopic submucosal dissection market is the increasing prevalence of gastrointestinal (GI) cancers, including esophageal, gastric, and colorectal cancers. These cancers often present as early-stage lesions that are amenable to treatment through endoscopic submucosal dissection, a minimally invasive procedure that allows for the en-bloc resection of tumors, reducing the risk of recurrence and the need for more invasive surgeries.

This rising incidence of GI cancers is attributed to factors such as unhealthy dietary habits, sedentary lifestyles, and an aging population, which have significantly increased the cases related to gastrointestinal diseases. As these diseases are often diagnosed at advanced stages, there is a growing emphasis on early detection and intervention.

The demand for endoscopic submucosal dissection procedures is further bolstered by advancements in endoscopic technology, such as improved imaging systems and electrosurgical tools, which enhance the safety and efficacy of the procedure. Additionally, the preference for minimally invasive treatments, which offer benefits like reduced recovery times and preservation of organ function, is contributing to the market's growth.

In summary, the increasing prevalence of gastrointestinal cancers, coupled with technological advancements in endoscopic procedures and a shift towards minimally invasive treatments, are pivotal factors driving the growth of the Endoscopic submucosal dissection market.

Despite the growth of the Endoscopic submucosal dissection market, several challenges persist. One of the primary challenges is the high level of technical expertise required to perform the procedure successfully. endoscopic submucosal dissection is a complex and delicate procedure that demands specialized skills and extensive experience. The risk of complications, such as bleeding or perforation, is higher compared to other less invasive techniques, and improper execution can lead to poor patient outcomes. As a result, the procedure is generally limited to specialized centers with highly trained endoscopists, restricting its availability and limiting its adoption in regions with fewer trained professionals.

Another challenge is the high cost of the procedure, which involves advanced endoscopic equipment, including specialized knives and electrosurgical tools. The need for sophisticated imaging systems, such as high-definition or high-magnification endoscopes, adds to the cost of endoscopic submucosal dissection. Additionally, the procedure often requires longer hospital stays and follow-up care, further increasing the financial burden on healthcare systems and patients.

Finally, patient selection is also a challenge. While endoscopic submucosal dissection is effective for early-stage gastrointestinal cancers, not all patients are suitable candidates. Factors like the size, location, and depth of the lesion, as well as the patient's overall health, can influence the success of the procedure. These limitations mean that endoscopic submucosal dissection may not be viable for all gastrointestinal tumors, and other treatments may be required, reducing the overall demand for this technique.

The global Endoscopic submucosal dissection market is highly competitive, with major players such as Olympus Corporation, Fujifilm Holdings Corporation, Boston Scientific Corporation, Medtronic, Sumitomo Bakelite Co., Ltd., Creo Medical Group PLC, Hoya Corporation, Conmed Corporation, Steris PLC, MTW Endoskopie Manufaktur, Ovesco Endoscopy AG, Zeon Medical Inc., Micro-Tech Endoscopy, Karl Storz SE & Co. KG, and Cook Medical leading the charge.

These companies play a crucial role in driving innovation and offering a wide range of advanced endoscopic equipment, tools, and technologies that enhance the safety, precision, and effectiveness of endoscopic submucosal dissection procedures. They are actively focusing on technological advancements such as improved imaging systems, electrosurgical tools, and robotics, which have significantly contributed to the growing adoption of endoscopic submucosal dissection as a minimally invasive treatment for gastrointestinal cancers. With ongoing product development and strategic partnerships, these companies are set to maintain their leadership positions in the market and contribute to the continued growth of the endoscopic submucosal dissection industry.

Endoscopic submucosal dissection Market Segmentation:

Segmentation 1: by Product

  • Gastroscopes And Colonoscopes
  • Knives
  • Injection Agents
  • Tissue Retractors
  • Graspers/Clips
  • Other Products

Segmentation 2: by Indication

  • Stomach Cancer
  • Colon Cancer
  • Esophageal Cancer

Segmentation 3: by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Other End Users

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

One of the most significant emerging trends in the global Endoscopic submucosal dissection market is the integration of robotic assistance and artificial intelligence (AI) into endoscopic submucosal dissection procedures. Robotic systems are enhancing the precision and control of surgeons, particularly in complex cases with large or challenging lesions.

These systems provide increased maneuverability and accuracy, allowing for more effective and safer dissections. Additionally, AI technologies are being incorporated to assist in lesion detection, characterization, and real-time guidance during procedures. AI-powered tools help endoscopists identify abnormalities more accurately, potentially reducing the risk of missed diagnoses and improving patient outcomes.

These advancements in robotics and AI are revolutionizing the endoscopic submucosal dissection field by improving precision, minimizing complications, and making the procedure more accessible, ultimately contributing to the continued growth and adoption of endoscopic submucosal dissection in gastrointestinal cancer treatment.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Endoscopic Submucosal Dissection Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Endoscopic Submucosal Dissection Market (by Product), ($Billion), 2024-2035

  • 2.1 Gastroscopes And Colonoscopes
  • 2.2 Knives
  • 2.3 Injection Agents
  • 2.4 Tissue Retractors
  • 2.5 Graspers/Clips
  • 2.6 Other Products

3. Global Endoscopic Submucosal Dissection Market (by Indication), ($Billion), 2024-2035

  • 3.1 Stomach Cancer
  • 3.2 Colon Cancer
  • 3.3 Esophageal Cancer

4. Global Endoscopic Submucosal Dissection Market (by End User), ($Billion), 2024-2035

  • 4.1 Hospitals
  • 4.2 Specialty Clinics
  • 4.3 Ambulatory Surgical Centres
  • 4.4 Other End Users

5. Global Endoscopic Submucosal Dissection Market (by Region), ($Billion), 2024-2035

  • 5.1 North America
    • 5.1.1 Key Findings
    • 5.1.2 Market Dynamics
    • 5.1.3 Market Sizing and Forecast
      • 5.1.3.1 North America Endoscopic Submucosal Dissection Market, by Country
        • 5.1.3.1.1 U.S.
        • 5.1.3.1.2 Canada
  • 5.2 Europe
    • 5.2.1 Key Findings
    • 5.2.2 Market Dynamics
    • 5.2.3 Market Sizing and Forecast
      • 5.2.3.1 Europe Endoscopic Submucosal Dissection Market, by Country
        • 5.2.3.1.1 Germany
        • 5.2.3.1.2 U.K.
        • 5.2.3.1.3 France
        • 5.2.3.1.4 Italy
        • 5.2.3.1.5 Spain
        • 5.2.3.1.6 Rest of the Europe
  • 5.3 Asia Pacific
    • 5.3.1 Key Findings
    • 5.3.2 Market Dynamics
    • 5.3.3 Market Sizing and Forecast
      • 5.3.3.1 Asia Pacific Endoscopic Submucosal Dissection Market, by Country
        • 5.3.3.1.1 China
        • 5.3.3.1.2 Japan
        • 5.3.3.1.3 India
        • 5.3.3.1.4 Australia
        • 5.3.3.1.5 Rest of Asia Pacific
  • 5.4 Rest of the World
    • 5.4.1 Key Findings
    • 5.4.2 Market Dynamics
    • 5.4.3 Market Sizing and Forecast

6. Global Endoscopic Submucosal Dissection Market: Competitive Landscape and Company Profiles

  • 6.1 Key Strategies and Development
    • 6.1.1 Mergers and Acquisitions
    • 6.1.2 Synergistic Activities
    • 6.1.3 Business Expansions and Funding
    • 6.1.4 Product Launches and Approvals
    • 6.1.5 Other Activities
  • 6.2 Company Profiles
    • 6.2.1 Fujifilm Holdings Corporation
      • 6.2.1.1 Overview
      • 6.2.1.2 Top Products / Product Portfolio
      • 6.2.1.3 Top Competitors
      • 6.2.1.4 Target Customers/End-Users
      • 6.2.1.5 Key Personnel
      • 6.2.1.6 Analyst View
    • 6.2.2 Olympus Corporation
      • 6.2.2.1 Overview
      • 6.2.2.2 Top Products / Product Portfolio
      • 6.2.2.3 Top Competitors
      • 6.2.2.4 Target Customers/End-Users
      • 6.2.2.5 Key Personnel
      • 6.2.2.6 Analyst View
    • 6.2.3 Boston Scientific Corporation
      • 6.2.3.1 Overview
      • 6.2.3.2 Top Products / Product Portfolio
      • 6.2.3.3 Top Competitors
      • 6.2.3.4 Target Customers/End-Users
      • 6.2.3.5 Key Personnel
      • 6.2.3.6 Analyst View
    • 6.2.4 Medtronic plc
      • 6.2.4.1 Overview
      • 6.2.4.2 Top Products / Product Portfolio
      • 6.2.4.3 Top Competitors
      • 6.2.4.4 Target Customers/End-Users
      • 6.2.4.5 Key Personnel
      • 6.2.4.6 Analyst View
    • 6.2.5 Sumitomo Bakelite Co., Ltd.
      • 6.2.5.1 Overview
      • 6.2.5.2 Top Products / Product Portfolio
      • 6.2.5.3 Top Competitors
      • 6.2.5.4 Target Customers/End-Users
      • 6.2.5.5 Key Personnel
      • 6.2.5.6 Analyst View
    • 6.2.6 Hoya Corporation
      • 6.2.6.1 Overview
      • 6.2.6.2 Top Products / Product Portfolio
      • 6.2.6.3 Top Competitors
      • 6.2.6.4 Target Customers/End-Users
      • 6.2.6.5 Key Personnel
      • 6.2.6.6 Analyst View
    • 6.2.7 Creo Medical Group PLC
      • 6.2.7.1 Overview
      • 6.2.7.2 Top Products / Product Portfolio
      • 6.2.7.3 Top Competitors
      • 6.2.7.4 Target Customers/End-Users
      • 6.2.7.5 Key Personnel
      • 6.2.7.6 Analyst View
    • 6.2.8 Conmed Corporation
      • 6.2.8.1 Overview
      • 6.2.8.2 Top Products / Product Portfolio
      • 6.2.8.3 Top Competitors
      • 6.2.8.4 Target Customers/End-Users
      • 6.2.8.5 Key Personnel
      • 6.2.8.6 Analyst View
    • 6.2.9 Steris PLC
      • 6.2.9.1 Overview
      • 6.2.9.2 Top Products / Product Portfolio
      • 6.2.9.3 Top Competitors
      • 6.2.9.4 Target Customers/End-Users
      • 6.2.9.5 Key Personnel
      • 6.2.9.6 Analyst View
    • 6.2.10 MTW Endoskopie Manufaktur
      • 6.2.10.1 Overview
      • 6.2.10.2 Top Products / Product Portfolio
      • 6.2.10.3 Top Competitors
      • 6.2.10.4 Target Customers/End-Users
      • 6.2.10.5 Key Personnel
      • 6.2.10.6 Analyst View
    • 6.2.11 Karl Storz SE & Co. KG
      • 6.2.11.1 Overview
      • 6.2.11.2 Top Products / Product Portfolio
      • 6.2.11.3 Top Competitors
      • 6.2.11.4 Target Customers/End-Users
      • 6.2.11.5 Key Personnel
      • 6.2.11.6 Analyst View
    • 6.2.12 Cook Medical
      • 6.2.12.1 Overview
      • 6.2.12.2 Top Products / Product Portfolio
      • 6.2.12.3 Top Competitors
      • 6.2.12.4 Target Customers/End-Users
      • 6.2.12.5 Key Personnel
      • 6.2.12.6 Analyst View
    • 6.2.13 Leo Medical Co., Ltd.
      • 6.2.13.1 Overview
      • 6.2.13.2 Top Products / Product Portfolio
      • 6.2.13.3 Top Competitors
      • 6.2.13.4 Target Customers/End-Users
      • 6.2.13.5 Key Personnel
      • 6.2.13.6 Analyst View
    • 6.2.14 Hangzhou AGS Medical Technological Co., Ltd.
      • 6.2.14.1 Overview
      • 6.2.14.2 Top Products / Product Portfolio
      • 6.2.14.3 Top Competitors
      • 6.2.14.4 Target Customers/End-Users
      • 6.2.14.5 Key Personnel
      • 6.2.14.6 Analyst View
    • 6.2.15 Beijing ZKSK Technology Co., Ltd.
      • 6.2.15.1 Overview
      • 6.2.15.2 Top Products / Product Portfolio
      • 6.2.15.3 Top Competitors
      • 6.2.15.4 Target Customers/End-Users
      • 6.2.15.5 Key Personnel
      • 6.2.15.6 Analyst View

7. Research Methodology

List of Figures

  • Figure: Global Endoscopic Submucosal Dissection Market (by Indication), $Billion, 2024 and 2035
  • Figure: Global Endoscopic Submucosal Dissection Market (by Product), $Billion, 2024 and 2035
  • Figure: Global Endoscopic Submucosal Dissection Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Endoscopic Submucosal Dissection Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Endoscopic Submucosal Dissection Market Key Trends, Analysis

List of Tables

  • Table: Global Endoscopic Submucosal Dissection Market Dynamics, Impact Analysis
  • Table: Global Endoscopic Submucosal Dissection Market (by Region), $Billion, 2024-2035